Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
FDA's New Approval Plan for COVID-19 Vaccines: An Inquiry of "Benefit" Rather than the Statutory Scope of "Safety, Purity, and Potency"?
Saved in:
| Published in: | Journal of Law and Health |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: FDA's New Approval Plan for COVID-19 Vaccines: An Inquiry of "Benefit" Rather than the Statutory Scope of "Safety, Purity, and Potency"?
- Repurpose an FDA‐Approved Antibody Using DARPin‐Scaffolded Bridge Protein
- Complement factor H supplementation rather than complete knockout provides therapeutic benefits in IgA nephropathy
- FDA Sentinel Initiative and Postmarket Drug Safety Surveillance
- Style-free references rather than standardized citation styles
- Community engagement for vaccine delivery in low- and middle-income countries and humanitarian settings: A scoping umbrella review
- An Ensemble Fuzzy-MCDM Approach for Evaluation of Approved Monkeypox Vaccines